Paul Hellstern

2.4k total citations
15 papers, 518 citations indexed

About

Paul Hellstern is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Paul Hellstern has authored 15 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Genetics and 5 papers in Surgery. Recurrent topics in Paul Hellstern's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Paul Hellstern is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Paul Hellstern collaborates with scholars based in United States, Italy and France. Paul Hellstern's co-authors include Silvio Danese, Séverine Vermeire, Miles Sparrow, Dino Tarabar, Maria Kłopocka, William J. Sandborn, Fabio Cataldi, Kenneth J. Gorelick, Д. А. Шапиро and Leigh MacConell and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

Paul Hellstern

14 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Hellstern United States 6 258 236 169 89 85 15 518
Nádia Duarte Portugal 12 123 0.5× 124 0.5× 413 2.4× 93 1.0× 75 0.9× 25 672
Idania Marrero United States 13 90 0.3× 185 0.8× 378 2.2× 75 0.8× 70 0.8× 22 588
A. Christopher Stevens United States 11 201 0.8× 231 1.0× 304 1.8× 149 1.7× 133 1.6× 13 789
M. B. Jacobsen Norway 11 99 0.4× 407 1.7× 192 1.1× 166 1.9× 276 3.2× 18 829
Sheila Pressman United States 8 485 1.9× 131 0.6× 307 1.8× 254 2.9× 43 0.5× 10 706
Amir Karban Israel 9 444 1.7× 246 1.0× 237 1.4× 240 2.7× 178 2.1× 18 849
Ahmet Eken Türkiye 14 91 0.4× 96 0.4× 399 2.4× 110 1.2× 71 0.8× 41 648
Tamara Pérez-Jeldres Chile 11 234 0.9× 158 0.7× 167 1.0× 134 1.5× 59 0.7× 21 540
Peter Eerligh Netherlands 12 285 1.1× 54 0.2× 290 1.7× 129 1.4× 34 0.4× 19 576

Countries citing papers authored by Paul Hellstern

Since Specialization
Citations

This map shows the geographic impact of Paul Hellstern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hellstern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hellstern more than expected).

Fields of papers citing papers by Paul Hellstern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hellstern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hellstern. The network helps show where Paul Hellstern may publish in the future.

Co-authorship network of co-authors of Paul Hellstern

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hellstern. A scholar is included among the top collaborators of Paul Hellstern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hellstern. Paul Hellstern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2021). Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II. Journal of Crohn s and Colitis. 15(6). 938–949. 25 indexed citations
2.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). DOP51 Biomarker and pharmacokinetic data from the TURANDOT II open-label extension study of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in patients with ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S058–S059. 2 indexed citations
3.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). DOP49 Efficacy of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in ulcerative colitis: results from the open-label extension study TURANDOT II. Journal of Crohn s and Colitis. 13(Supplement_1). S056–S057. 5 indexed citations
4.
Danese, Silvio, William J. Sandborn, Walter Reinisch, et al.. (2019). 772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II. The American Journal of Gastroenterology. 114(1). S448–S449. 1 indexed citations
5.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). Tu1737 – Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Ulcerative Colitis: Results from the Open-Label Extension Study Turandot Ii. Gastroenterology. 156(6). S–1105. 1 indexed citations
6.
Pockros, Paul J., Michael Fuchs, B. Freilich, et al.. (2019). CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. Liver International. 39(11). 2082–2093. 136 indexed citations
7.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). P036 LONG-TERM SAFETY AND EFFICACY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II). Gastroenterology. 156(3). S25–S26. 1 indexed citations
8.
Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). P036 LONG-TERM SAFETY AND EFFICACY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II). Inflammatory Bowel Diseases. 25(Supplement_1). S18–S18. 4 indexed citations
9.
Vermeire, Séverine, William J. Sandborn, Silvio Danese, et al.. (2017). Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. 390(10090). 135–144. 146 indexed citations
10.
Danese, Silvio, Séverine Vermeire, Paul Hellstern, et al.. (2017). Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II). Gut. 68(1). 40–48. 136 indexed citations
11.
Danese, Silvio, Séverine Vermeire, Paul Hellstern, et al.. (2016). 764 Results of Andante, a Randomized Clinical Study With an Anti-IL6 Antibody (PF-04236921) in Subjects With Crohn's Disease Who Are Anti-TNF Inadequate Responders. Gastroenterology. 150(4). S155–S155. 4 indexed citations
12.
13.
Köhler, Michael, et al.. (2008). Behandlung des von-Willebrand-Jürgens-Syndroms mit »hepatitissicheren« Faktor-VIII-Konzentraten. DMW - Deutsche Medizinische Wochenschrift. 109(47). 1800–1805.
14.
Baldus, M., et al.. (1998). Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.. PubMed. 49(3). 186–92. 4 indexed citations
15.
Seiler, D., Donald Nagel, H. E. Franz, et al.. (1989). Effects of Long-Distance Running on Iron Metabolism and Hematological Parameters. International Journal of Sports Medicine. 10(5). 357–362. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nádia Duarte Breakdown of academic impact, for papers by Idania Marrero Breakdown of academic impact, for papers by A. Christopher Stevens Breakdown of academic impact, for papers by M. B. Jacobsen Breakdown of academic impact, for papers by Sheila Pressman Breakdown of academic impact, for papers by Amir Karban Breakdown of academic impact, for papers by Ahmet Eken Breakdown of academic impact, for papers by Tamara Pérez-Jeldres Breakdown of academic impact, for papers by Peter Eerligh
Rankless by CCL
2026